Milton Hodosh and Richardson-Vicks, Inc. v. Block Drug Company, Inc.

786 F.2d 1136, 229 U.S.P.Q. (BNA) 182, 1986 U.S. App. LEXIS 20042
CourtCourt of Appeals for the Federal Circuit
DecidedMarch 24, 1986
DocketAppeal 85-2607
StatusPublished
Cited by66 cases

This text of 786 F.2d 1136 (Milton Hodosh and Richardson-Vicks, Inc. v. Block Drug Company, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Milton Hodosh and Richardson-Vicks, Inc. v. Block Drug Company, Inc., 786 F.2d 1136, 229 U.S.P.Q. (BNA) 182, 1986 U.S. App. LEXIS 20042 (Fed. Cir. 1986).

Opinion

RICH, Circuit Judge.

This appeal is from the July 12, 1985, judgment of the United States District Court for the District of New Jersey, 226 USPQ 645, granting summary judgment to Block Drug Company, Inc., et al. (Block) and holding that all six claims of patent No. 3,863,006 for “Method of Desensitizing Teeth” (’006 patent), issued to Dr. Milton Hodosh and licensed to Richardson-Vicks, Inc. (collectively, Hodosh), are invalid for obviousness under 35 U.S.C. § 103. We reverse and remand.

Background

Tooth desensitizers, reduce discomfort and pain caused by tooth hypersensitivity or exposed dentin, the portion of the tooth between the enamel and the pulp which includes a myriad of microscopic tubules. Persons suffering from this condition react painfully to hot or cold foods, citric acid or sweets, or everyday chemical, thermal, or tactile stimuli including toothbrush contact.

Milton Hodosh, a practicing dentist for about thirty years, independently developed the claimed subject matter of the ’006 patent and granted Richardson-Vicks an exclusive license to make, use, and sell the claimed invention; the latter markets its tooth desensitizing toothpaste under the trademark “Denquel.”

Claim 1 of the ’006 patent 1 reads:

The method of desensitizing hypersensitive dentin and cementum by applying thereto an agent the essential ingredient of which is a nitrate of one of the following alkali metals: potassium, lithium or sodium said nitrate comprising between 1 percent and 20 percent by weight of said agent.

The remaining claims appear in the opinion below.

Appellee Block has, since 1961, marketed a tooth desensitizing toothpaste, covered by its patent No. 2,122,483 (the Rosenthal patent) for “Strontium Ion Toothpaste” issued in 1964, under the trademark “Sensodyne.” The Rosenthal patent and the ’006 patent disclose toothpaste formulae which are the same except that the latter contains, as a desensitizing agent, potassium-nitrate instead of the Rosenthal-Block strontium chloride. After requesting and being denied a license under the ’006 patent, Block developed its own potassium nitrate-containing tooth-desensitizing toothpaste called “Promise” and “SensodyneF.” 2

March 30,1983, Hodosh sued Block alleging that the sale of “Promise” and “Sensodyne-F” contributorily infringed and actively induced infringement of the ’006 patent. Block answered and counterclaimed alleging patent misuse and consequent unenforceability of the ’006 patent. On July 11, 1984, Block moved for summary judgment as to both misuse and patent invalidity. Oral argument was heard October 16,1984, and decision was reserved. June 14, 1985, *1138 the reported decision was handed down granting the motion as to patent invalidity and dismissing the motion on misuse as moot, resulting in the judgment now on appeal.

The district court heard no expert testimony, but did hear arguments of counsel, receive briefs, review exhibits, and had before it declarations and affidavits from experts on both sides commenting on the eight prior art references involved here, including the Rosenthal patent. The court determined that there were no genuine issues of material fact and concluded as a matter of law that the claims of the ’006 patent were invalid under § 103 because the Rosenthal patent disclosed each element claimed in the ’006 patent except the potassium nitrate, which, in its view, was disclosed in two Chinese references, both based on ancient Chinese writings. The court also stated that six European references supported its conclusion of obviousness.

Because the appropriateness of summary judgment is determined on an analysis of the facts, First National Bank of Arizona v. Cities Service Co., 391 U.S. 253, 88 S.Ct. 1575, 20 L.Ed.2d 569 (1968), and because everything about these references, as a whole, see, e.g., Interconnect Planning Corp. v. Feil, 774 F.2d 1132, 1138, 227 USPQ 543, 547-48 (Fed.Cir.1985), is important to our determination, we review the record and lay out the relevant portions of the references in some detail.

A. The Chinese References

1. The Grand Dictionary of Chinese Medicine and Drugs (The Grand Dictionary)

The Grand Dictionary, published in Hong Kong in 1963 and written in Chinese, is based on ancient Chinese compilations assembled roughly 500 years ago from works of physicians going back 4000-5000 years. Only a portion of the 1963 Chinese text was before the court and is before us on appeal. For purposes of this litigation, that portion was translated into English by Block’s translator, Roger Wei-Ming Tsao (Mr. Cao). Mr. Cao is a doctor of Chinese medicine and a bilingual tutor. Block’s other expert, Dr. Stephen Wei, a professor of dentistry fluent in Chinese, concurred in that translation. The writings from which the Grand Dictionary was compiled are not in evidence nor are any earlier writings.

In a nutshell, the district court relied upon the Grand Dictionary because of its discussion of “xiao shi” to which the Grand Dictionary associates the name “niter” and the chemical composition KNOs and the ability to cure, inter alia, tooth pain. The court’s opinion was that this reference teaches the use of xiao shi, which is the same as niter and is therefore the same as potassium nitrate, to cure tooth pain; thus, the teachings of the Rosenthal patent and the Grand Dictionary show that the '006 invention would have been obvious.

The following discussion and quotations are part of an attempt to convey the nature of the Grand Dictionary. The translated portion of the Grand Dictionary is entitled “Niter.” The text under the first subheading “Nomenclature” reads: “It was so named because it has the power to consume various stones.” Under “Other Names Stated in Classical Medical Books,” the text reads “Mang Xiao (Bie-Lu), Bitter Xiao (Zhen-Quan), Flaming Xiao (Tu-Su) ... and Xiao-Shi ____” Thereafter, following “Foreign Names,” the Grand Dictionary reads: “Salpetrae, Salnitri (in Latin); Niter (in English); and Salpoter (in German).” One page later, “KN03” is listed under “Chemical Composition.”

The portion upon which Block and the district court rely to show that this substance cures tooth pain is headed “Collective Statements” and reads:

(Ming): Li-Shi-Zhen said: It cures summer infections and the catching of colds. It cures acute enteritis with severe vomiting, exertion through excessive sexual activity, black jaundice, chronic abdominal pain, conjunctivitis, headaches and tooth pain.

The next three or so pages of the Grand Dictionary list the ailments that this substance cures.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Enfield Enterprises, Inc.
Armed Services Board of Contract Appeals, 2024
Doane v. United States
369 F. Supp. 3d 422 (N.D. New York, 2019)
Realtime Data, LLC v. Stanley
897 F. Supp. 2d 146 (S.D. New York, 2012)
Link Treasure Ltd. v. Baby Trend, Inc.
809 F. Supp. 2d 1191 (C.D. California, 2011)
Mitsubishi Chemical Corp. v. Barr Laboratories, Inc.
435 F. App'x 927 (Federal Circuit, 2011)
Lucent Technologies, Inc. v. Gateway, Inc.
580 F.3d 1301 (Federal Circuit, 2009)
Alloc, Inc. v. Norman D. Lifton Co.
653 F. Supp. 2d 469 (S.D. New York, 2009)
Kowalski v. Mommy Gina Tuna Resources
574 F. Supp. 2d 1160 (D. Hawaii, 2008)
Kowalski v. Mummy Gina Tuna Resources
574 F. Supp. 2d 1165 (D. Hawaii, 2008)
Tyco Healthcare Group LP v. Ethicon Endo-Surgery, Inc.
514 F. Supp. 2d 351 (D. Connecticut, 2007)
Advanced Technology Materials, Inc. v. Praxair, Inc.
228 F. App'x 983 (Federal Circuit, 2007)
Holland v. United States
75 Fed. Cl. 483 (Federal Claims, 2007)
Astoria Federal Savings & Loan Ass'n v. United States
72 Fed. Cl. 712 (Federal Claims, 2006)
McNeil-PPC, Inc. v. Perrigo Co.
443 F. Supp. 2d 492 (S.D. New York, 2006)
Northeast Savings v. United States
72 Fed. Cl. 173 (Federal Claims, 2006)
IXYS Corp. v. Advanced Power Technology, Inc.
321 F. Supp. 2d 1133 (N.D. California, 2004)
Canady v. Erbe Elektromedizin GmbH
271 F. Supp. 2d 64 (District of Columbia, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
786 F.2d 1136, 229 U.S.P.Q. (BNA) 182, 1986 U.S. App. LEXIS 20042, Counsel Stack Legal Research, https://law.counselstack.com/opinion/milton-hodosh-and-richardson-vicks-inc-v-block-drug-company-inc-cafc-1986.